Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,893 | 260 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $912.69 | 41 | $0 (2024) |
| Lilly USA, LLC | $722.37 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $663.98 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $588.33 | 17 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $498.32 | 17 | $0 (2024) |
| Gilead Sciences, Inc. | $495.00 | 4 | $0 (2024) |
| ABBVIE INC. | $367.52 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $335.99 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $311.51 | 17 | $0 (2024) |
| Corcept Therapeutics | $217.38 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,375 | 116 | Novo Nordisk Inc ($517.10) |
| 2023 | $2,140 | 86 | Lilly USA, LLC ($516.94) |
| 2022 | $1,377 | 58 | Boehringer Ingelheim Pharmaceuticals, Inc. ($402.69) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $7.84 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Diabetes Care | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.66 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 12/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Endocrinology | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $11.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $25.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: DIABETES | ||||||
| 10/23/2024 | Xeris Pharmaceuticals, Inc. | RECORLEV (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Adrenal steroidogenesis inhibitor | ||||||
| 10/22/2024 | Gilead Sciences, Inc. | Epclusa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: HCV | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 3 | 48 | 86 | $5,962 | $2,130 |
| 2020 | 4 | 70 | 76 | $9,816 | $3,648 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 24 | $5,160 | $1,982 | 38.4% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 11 | 14 | $742.00 | $129.81 | 17.5% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 13 | 48 | $60.00 | $18.15 | 30.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 22 | 24 | $5,160 | $1,979 | 38.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 24 | 27 | $3,942 | $1,507 | 38.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 11 | 12 | $636.00 | $132.38 | 20.8% |
| 81003 | Automated urinalysis test | Office | 2020 | 13 | 13 | $78.00 | $28.90 | 37.1% |
About Peter Rodriguez, P.A
Peter Rodriguez, P.A is a Physician Assistant healthcare provider based in Lancaster, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225132764.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Rodriguez, P.A has received a total of $6,893 in payments from pharmaceutical and medical device companies, with $3,375 received in 2024. These payments were reported across 260 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($6,893).
As a Medicare-enrolled provider, Rodriguez has provided services to 118 Medicare beneficiaries, totaling 162 services with total Medicare billing of $5,777. Data is available for 2 years (2020–2021), covering 7 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Lancaster, CA
- Active Since 09/12/2006
- Last Updated 07/08/2007
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1225132764
Products in Payments
- JARDIANCE (Drug) $591.36
- MOUNJARO (Drug) $567.88
- Epclusa (Drug) $495.00
- REXULTI (Drug) $353.02
- Ozempic (Drug) $337.35
- AIRSUPRA (Drug) $327.54
- VERQUVO (Drug) $300.81
- VRAYLAR (Drug) $273.97
- BELSOMRA (Drug) $267.56
- Wegovy (Drug) $218.34
- Korlym (Drug) $217.38
- Rybelsus (Drug) $209.24
- VOQUEZNA (Drug) $199.74
- TRELEGY ELLIPTA (Drug) $192.21
- Kerendia (Drug) $172.74
- AREXVY (Drug) $124.99
- YUPELRI (Drug) $117.29
- ZENPEP (Drug) $116.42
- Linzess (Drug) $108.18
- QUVIVIQ (Drug) $99.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Lancaster
Michael Shipman, Pac, PAC
Physician Assistant — Payments: $12,300
Mr. Cole Pizzingrilli, Pa-C, PA-C
Physician Assistant — Payments: $11,591
Heather Coyne, Pa-C, PA-C
Physician Assistant — Payments: $10,455
Simarjeet Manocha, Pa-C, PA-C
Physician Assistant — Payments: $8,781
Ms. Laura Pastrana Gutierrez, Pa-C, PA-C
Physician Assistant — Payments: $7,156
Bethany Arbogast, Pa-C, PA-C
Physician Assistant — Payments: $5,353